Visalytics
Visalytics
approved EB-2 (NIW)

Scientist

Chemistry · Nepal · 2025-02-20

Processing Time
14 days
Decision Date
2025-02-20
Location
Arkansas
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to synthesize novel engineered nanoplatforms for therapeutic applications and develop non-cell culture-based efficacy determination methods for targeting therapeutic nanomaterials. The work aims to create cancer treatments with high specificity to improve treatment effectiveness while reducing off-target effects.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses pressing medical challenges by transforming targeted cancer therapeutics through nanomaterial chemistry.

2 Well-positioned to Advance the Endeavor Met

The petitioner demonstrated success through 11 peer-reviewed articles, 429 citations, and securing funding from major national agencies like the NIH and NSF.

3 Balance of Factors to Waive Job Offer Met

The potential for life-saving innovations in cancer treatment and benefits to public health outweighed the need for a labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 11 peer-reviewed journal articles (5 first-authored) and 8 conference abstracts, which garnered 429 citations. The case was further strengthened by evidence of research funding from the National Science Foundation (NSF) and the National Institutes of Health (NIH), satisfying the Dhanasar prongs for national importance and being well-positioned.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Conference Presentations
Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · Bangladesh

WeGreened EB-2 (NIW) approved
Massachusetts 309 days 2025-04-01
The petitioner proposes to continue research in the United States focused on synthesizing tumor-targeted nanocarriers for RNA therapeutic delivery and improving mRNA purification systems. This work aims to develop cost-effective and scalable solutions for cancer vaccines and RNA-based therapies. The endeavor is designed to address critical challenges in cancer therapy and vaccine manufacturing.
View Case

Postdoctoral Researcher

Materials Science · Russia

WeGreened EB-2 (NIW) approved
Michigan 8 days 2023-02-15
The petitioner proposes to employ state-of-the-art nanoscience techniques to characterize, develop, and enhance functional nanomaterials for biomedical and photonics applications. Her work focuses on improving treatment options for diseases like cancer and advancing optoelectronic devices through the development of cutting-edge nanoparticles for drug delivery.
View Case

Consultant

Biotechnology · Turkey

WeGreened EB-2 (NIW) approved
2 days 2023-08-24
The petitioner proposes to continue research on developing cutting-edge nanotherapeutic and nanotheranostic systems, as well as toxicology assays. This work focuses on improving cancer diagnosis and treatment while evaluating and reducing the toxicity of biomedical materials and devices.
View Case

Research Fellow

Biotechnology · India

WeGreened EB-2 (NIW) approved
Florida 48 days 2025-09-04
The petitioner proposes to develop precision oncology tools by integrating nanotechnology, immunology, and computational methods to engineer next-generation cancer therapies. His work specifically focuses on designing personalized, neoantigen-based nano vaccines and SMART-lipid nanoparticles to improve immune system responsiveness and overcome tumor immune evasion.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Nepal

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-02-20.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 14 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Nepal All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist